MedTrace Logo

Management Of Acute Disseminating Encephalomyelitis

NCT03284801 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-09-15

No results posted yet for this study

Summary

Acute disseminated encephalomyelitis is an immune-mediated inflammatory demyelinating disease of the central nervous system, which is typically transitory and self-limiting. It is characterized by an acute or subacute encephalopathy with neurological deficits, and magnetic resonance imaging evidence of widespread demyelination that predominantly involves the white matter of the brain and spinal cord. In the absence of specific biological markers, the diagnosis of Acute disseminated encephalomyelitis is still based upon a combination of clinical and neuro imaging features and exclusion of diseases that mimic Acute disseminated encephalomyelitis

Conditions

  • Acute Disseminated Encephalomyelitis

Interventions

OTHER

management of acute disseminating encephalomyelitis

clinical audit on management of acute disseminating encephalomyelitis

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Marwa Alsaid Ahmed, resident doctor · Assiut University

Eligibility

Min Age
12 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-31
Primary Completion
2019-01-31
Completion
2019-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03284801 on ClinicalTrials.gov